Intravoxel incoherent motion (IVIM)-derived perfusion fraction mapping for the visual evaluation of MR-guided high intensity focused ultrasound (MR-HIFU) ablation of uterine fibroids

References

• Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):1–10. doi:10.1067/MOB.2003.99.
   Web of Science ®Google Scholar
• Yang Q, Ciebiera M, Bariani MV, et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocr Rev. 2022;43(4):678–719. Aug doi: 10.1210/endrev/bnab039.
   PubMed Web of Science ®Google Scholar
• Stewart EA. Uterine fibroids. Lancet. 2001;357(9252):293–298. doi: 10.1016/S0140-6736(00)03622-9.
   PubMed Web of Science ®Google Scholar
• Cardozo ER, Clark AD, Banks NK, et al. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211.e1–211.e9. doi: 10.1016/j.ajog.2011.12.002.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, Anneveldt KJ, Nijholt IM, et al. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: a systematic review and meta-analysis. Eur J Radiol. 2019;120:108700. doi: 10.1016/j.ejrad.2019.108700.
   PubMed Web of Science ®Google Scholar
• Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery – Results of different treatment protocols. Radiology. 2007;243(3):885–893. doi: 10.1148/radiol.2433060267.
   PubMed Web of Science ®Google Scholar
• Park MJ, Kim YS, Rhim H, et al. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. J Vasc Interv Radiol. 2014;25(2):231–239. doi: 10.1016/j.jvir.2013.11.011.
   PubMed Web of Science ®Google Scholar
• Al Hilli MM, Stewart EA. Magnetic resonance-guided focused ultrasound surgery. Semin Reprod Med. 2010;28(3):242–249. doi: 10.1055/s-0030-1251481.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Gostout B, Rabinovici J, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110(2 Pt 1):279–287. doi: 10.1097/01.AOG.0000275283.39475.f6.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, de Boer JP, Linstra M, et al. The focused ultrasound myoma outcome study (FUMOS); a retrospective cohort study on long-term outcomes of MR-HIFU therapy. Eur Radiol. 2020;30(5):2473–2482. doi: 10.1007/s00330-019-06641-7.
   PubMed Web of Science ®Google Scholar
• Zheng S, Rong Y, Zhu H, et al. Role of magnetic resonance-high intensity focused ultrasound (MR-HIFU) in uterine fibroids management: an updated systematic review and meta-analysis. Wideochir Inne Tech Maloinwazyjne. 2022;17(1):83–94. doi: 10.5114/wiitm.2021.109760.
   PubMedGoogle Scholar
• Hijnen NM, Elevelt A, Pikkemaat J, et al. The magnetic susceptibility effect of gadolinium-based contrast agents on PRFS-based MR thermometry during thermal interventions. J Ther Ultrasound. 2013;1(1):8. doi: 10.1186/2050-5736-1-8.
   PubMedGoogle Scholar
• Hectors SJCG, Jacobs I, Moonen CTW, et al. MRI methods for the evaluation of high intensity focused ultrasound tumor treatment: current status and future needs. Magn Reson Med. 2016;75(1):302–317. doi: 10.1002/mrm.25758.
   PubMed Web of Science ®Google Scholar
• Verpalen IM. Diffusion-weighted imaging to monitor treatment progression of magnetic resonance guided focused ultrasound fibroid ablation. Improving treatment efficacy of MR-HIFU fibroid ablation, Thesis, 2021, p. 131–148.
   Google Scholar
• Liao D, Xiao Z, Lv F, et al. Non-contrast enhanced MRI for assessment of uterine fibroids’ early response to ultrasound-guided high-intensity focused ultrasound thermal ablation. Eur J Radiol. 2020;122:108670. doi: 10.1016/j.ejrad.2019.108670.
   PubMed Web of Science ®Google Scholar
• Pilatou MC, Stewart EA, Maier SE, et al. MRI-based thermal dosimetry and diffusion-weighted imaging of MRI-Guided focused ultrasound thermal ablation of uterine fibroids. J Magn Reson Imaging. 2009;29(2):404–411. doi: 10.1002/JMRI.21688.
   PubMed Web of Science ®Google Scholar
• Slotman DJ, Bartels LW, Zijlstra A, et al. Diffusion-weighted MRI with deep learning for visualizing treatment results of MR-guided HIFU ablation of uterine fibroids. Eur Radiol. 2022;33(6):4178–4188. doi: 10.1007/s00330-022-09294-1.
   PubMed Web of Science ®Google Scholar
• Ikink ME, et al. IntraVoxel incoherent motion MRI for the characterization of uterine fibroids before MR-guided high-intensity focused ultrasound ablation. in Proceedings of the Joint Annual Meeting International Society for Magnetic Resonance in Medicine – European Society for Magnetic Resonance in Medicine and Biology, May 2014, p. 3693.
   Google Scholar
• Qu F, Hor P-H, Fischer J, et al. Tissue characterization of uterine fibroids with an intravoxel incoherent motion model: the need for T2 correction. J Magn Reson Imaging. 2018;48(4):994–1001. doi: 10.1002/JMRI.25988.
   PubMed Web of Science ®Google Scholar
• Andrews S, Yuan Q, Bailey A, et al. Multiparametric MRI characterization of funaki types of uterine fibroids considered for MR-guided high-intensity focused ultrasound (MR-HIFU) therapy. Acad Radiol. 2019;26(4):e9–e17. Apr doi: 10.1016/j.acra.2018.05.012.
   PubMedGoogle Scholar
• Tang N, Gu J, Yin X, et al. Evaluation value of intravoxel incoherent motion diffusion-weighted imaging on early efficacy of magnetic resonance-guided high-intensity focused ultrasound ablation for uterine adenomyoma. J. Shanghai Jiaotong Univ. (Sci.). 2022;27(2):226–230. doi: 10.1007/s12204-022-2405-x.
   Google Scholar
• Jiang Y, Qin S, Wang Y, et al. Intravoxel incoherent motion diffusion-weighted MRI for predicting the efficacy of high-intensity focused ultrasound ablation for uterine fibroids. Front Oncol. 2023;13:1178649. doi: 10.3389/fonc.2023.1178649.
   PubMed Web of Science ®Google Scholar
• Barbieri S, Gurney-Champion OJ, Klaassen R, et al. Deep learning how to fit an intravoxel incoherent motion model to diffusion-weighted MRI. Magn Reson Med. 2020;83(1):312–321. doi: 10.1002/mrm.27910.
   PubMed Web of Science ®Google Scholar
• Kaandorp MPT, Barbieri S, Klaassen R, et al. Improved unsupervised physics-informed deep learning for intravoxel incoherent motion modeling and evaluation in pancreatic cancer patients. Magn Reson Med. 2021;86(4):2250–2265. https://arxiv.org/abs/2011.01689v2. doi: 10.1002/mrm.28852.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, Anneveldt KJ, Vos PC, et al. Use of multiparametric MRI to characterize uterine fibroid tissue types. Magn Reson Mater Phy. 2020;33(5):689–700. doi: 10.1007/s10334-020-00841-9.
   Web of Science ®Google Scholar
• Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161(2):401–407. doi: 10.1148/radiology.161.2.3763909.
   PubMed Web of Science ®Google Scholar
• Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505. doi: 10.1148/radiology.168.2.3393671.
   PubMed Web of Science ®Google Scholar
• Zhu L, Lu W, Wang F, et al. Study of T2 mapping in quantifying and discriminating uterine lesions under different magnetic field strengths: 1.5 T vs. 3.0 T. BMC Med Imaging. 2023;23(1):1. doi: 10.1186/s12880-022-00960-w.
   PubMed Web of Science ®Google Scholar
• Barth M, Moser E. Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI. Cell. Mol. Biol. (Noisy-Le-Grand). 1997;43(5):783–791.
   PubMed Web of Science ®Google Scholar
• Virtanen P, Gommers R, Oliphant TE, et al. SciPy 1.0–fundamental algorithms for scientific computing in python. Nat Method. 2019;17(3):261–272. doi: 10.1038/s41592-019-0686-2.
   Web of Science ®Google Scholar
• Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia. 1994;10(4):457–483. doi: 10.3109/02656739409009351.
   PubMed Web of Science ®Google Scholar
• Morochnik S, Ozhinsky E, Rieke V, et al. T2 mapping as a predictor of nonperfused volume in MRgFUS treatment of desmoid tumors. Int J Hyperthermia. 2019;36(1):1272–1277. doi: 10.1080/02656736.2019.1698773.
   PubMed Web of Science ®Google Scholar
• Sainio T, Saunavaara J, Komar G, et al. Feasibility of T2 relaxation time in predicting the technical outcome of MR-guided high-intensity focused ultrasound treatment of uterine fibroids. Int J Hyperthermia. 2021;38(1):1384–1393. doi: 10.1080/02656736.2021.1976850.
   PubMed Web of Science ®Google Scholar